High reputation Vulcanising Agent Dtdm Powder - Dexamethasone acetate ointment – KeMing Medicines Detail:
FOB Price | Inquiry |
Min.Order Quantity | 50,000 Vias |
Supply Ability | 8,000,000 tubes/Month |
Port | Shanghai |
Payment Terms | T/T in advance |
Product Detail | |
Product name | Dexamethasone acetate ointment |
Specification | 15mg/20g |
Description | A white cream |
Standard | CP |
Package | 1Via/box |
Transportation | Ocean,Land,Air |
Certificate | GMP |
Price | Inquiry |
Quality guaranteeperiod | for 36 months |
Product Description | [INDICATION] Affections inflammatoires telles eczémas, affections prolifératives telles psoriasis, affections auto-immunes telles lupus érythémateux, affections tumorales telles mycosis fongoïde. L’indication d’une corticothérapie locale doit être correctement évaluée et il convient d’expliquer au patient l’utilité et les risques d’un tel traitement. |
Product detail pictures:
Related Product Guide:
Medication & Dietary Supplement Interactions – What You Should Know about Drugs and Vitamins
Disease, Doctors, Drugs and Vitamins!
Our business puts emphasis over the administration, the introduction of talented staff, plus the construction of employees building, striving hard to boost the standard and liability consciousness of staff members. Our corporation successfully attained IS9001 Certification and European CE Certification of High reputation Vulcanising Agent Dtdm Powder - Dexamethasone acetate ointment – KeMing Medicines, The product will supply to all over the world, such as: Sri Lanka, Karachi, Chicago, We hope we can establish long-term cooperation with all of the customers. And hope we can improve competitiveness and achieve the win-win situation together with the customers. We sincerely welcome the customers from all over the world to contact us for anything you need!
By Arthur from venezuela - 2017.08.16 13:39
Hope that the company could stick to the enterprise spirit of "Quality, Efficiency, Innovation and Integrity", it will be better and better in the future.
By Page from Philadelphia - 2017.12.09 14:01